Immunotherapy for Patients with Advanced Urothelial Cancer: Current Evidence and Future Perspectives

Immunotherapy for Patients with Advanced Urothelial Cancer: Current Evidence and Future Perspectives

In recent years, immunotherapy has produced encouraging results in a rapidly increasing number of solid tumors. The responsiveness of bladder cancer to immunotherapy was first established in nonmuscle invasive disease in 1976 with intravesical instillations of bacillus Calmette-Guérin (BCG). Very re...

Full description

Bibliographic Details
Main Authors:	Clizia Zichi, Marcello Tucci, Gianmarco Leone, Consuelo Buttigliero, Francesca Vignani, Daniele Pignataro, Giorgio V. Scagliotti, Massimo Di Maio
Format:	Article
Language:	English
Published:	Hindawi Limited 2017-01-01
Series:	BioMed Research International
Online Access:	http://dx.doi.org/10.1155/2017/5618174

Similar Items

Enzalutamide-resistant castration-resistant prostate cancer: challenges and solutions
by: Tucci M, et al.
Published: (2018-10-01)

Evaluation of Cognitive Function in Trials Testing New-Generation Hormonal Therapy in Patients with Prostate Cancer: A Systematic Review
by: Laura Marandino, et al.
Published: (2020-09-01)

FOLFOX activity in a rare case of metastatic colonic adenocarcinoma of the tongue: a case report
by: Clizia Zichi, et al.
Published: (2018-04-01)

Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment
by: Michele Iuliani, et al.
Published: (2015-12-01)

Systemic Immunotherapy for Urothelial Cancer: Current Trends and Future Directions
by: Shilpa Gupta, et al.
Published: (2017-01-01)

Current Status and Future Perspectives of Immunotherapy for Locally Advanced or Metastatic Urothelial Carcinoma: A Comprehensive Review
by: Tae Jin Kim, et al.
Published: (2020-01-01)

Urothelial carcinoma: the evolving landscape of immunotherapy for patients with advanced disease
by: Dietrich B, et al.
Published: (2018-01-01)

Transcriptional Profiling of Advanced Urothelial Cancer Predicts Prognosis and Response to Immunotherapy
by: Seung-Woo Baek, et al.
Published: (2020-03-01)

Second-line treatment options in hepatocellular carcinoma
by: Donatella Marino, et al.
Published: (2019-04-01)

Immunotherapy advisory council for urothelial cancer
by: Article Editorial
Published: (2019-07-01)

Immunotherapy in urothelial cancer: recent data and perspectives
by: M. I. Volkova, et al.
Published: (2018-01-01)

Immunotherapy for Urothelial Carcinoma: Current Status and Perspectives
by: Taiji Tsukamoto, et al.
Published: (2011-07-01)

Neoadjuvant Immunotherapy: The Next Gold Standard Before Radical Surgery for Urothelial Cancer
by: Daniele Raggi, et al.
Published: (2021-08-01)

Role of immunotherapy in localized muscle invasive urothelial cancer
by: Jasmeet Kaur, et al.
Published: (2021-09-01)

Glycogen Metabolism Predicts the Efficacy of Immunotherapy for Urothelial Carcinoma
by: Yueming Zhang, et al.
Published: (2021-08-01)

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of urothelial cancer
by: Gary D Steinberg, et al.
Published: (2021-07-01)

First-line maintenance immunotherapy in advanced urothelial cancers: Practice changing implications of the JAVELIN bladder 100 trial
by: Santosh Kumaraswamy
Published: (2021-01-01)

FGFR3 Alterations in the Era of Immunotherapy for Urothelial Bladder Cancer
by: Alec Kacew, et al.
Published: (2020-11-01)

Aristolochic Acid and Immunotherapy for Urothelial Carcinoma: Directions for unmet Needs
by: Huang-Yu Yang, et al.
Published: (2019-06-01)

Novel immunotherapy approaches for metastatic urothelial and renal cell carcinoma
by: Zhiying Shao, et al.
Published: (2016-10-01)

COX-2 inhibition : a role in the immunotherapy of urothelial carcinoma?
by: Dovedi, Simon Julian
Published: (2006)

Advances in diagnosis and treatment of malignant pleural mesothelioma
by: Giorgio Vittorio Scagliotti, et al.
Published: (2011-12-01)

Advances in diagnosis and treatment of malignant pleural mesothelioma
by: Giorgio Vittorio Scagliotti, et al.
Published: (2011-12-01)

Sublingual Immunotherapy: Recent Advances
by: Enrico Compalati, et al.
Published: (2013-01-01)

Immunotherapy for hepatocellular carcinoma: recent advances and future perspectives
by: Weiqi Xu, et al.
Published: (2019-07-01)

Immunotherapy in Prostate Cancer: Recent Advances and Future Directions
by: Ida Silvestri, et al.
Published: (2019-05-01)

Immunotherapy for Hepatocellular Carcinoma: Current Advances and Future Expectations
by: Yingjun Xie, et al.
Published: (2018-01-01)

Delivery strategies of cancer immunotherapy: recent advances and future perspectives
by: Zhongwei Zhao, et al.
Published: (2019-11-01)

Immune Checkpoint Inhibitors in Urothelial Bladder Cancer: State of the Art and Future Perspectives
by: Giandomenico Roviello, et al.
Published: (2021-08-01)

Neoadjuvant immunotherapy for muscle invasive urothelial bladder carcinoma: will it change current standards?
by: Alex Renner, et al.
Published: (2021-07-01)

Wnt/β-Catenin Signaling and Immunotherapy Resistance: Lessons for the Treatment of Urothelial Carcinoma
by: Alexander Chehrazi-Raffle, et al.
Published: (2021-02-01)

Immunotherapy in the Treatment of Urothelial Bladder Cancer: Insights From Single-Cell Analysis
by: Jingyu Zang, et al.
Published: (2021-05-01)

Pulmonary sarcomatoid carcinoma: Future prospects of adjuvant immunotherapy in advanced management
by: Anand Agrawal
Published: (2020-01-01)

Engineering nanoparticles to reprogram radiotherapy and immunotherapy: recent advances and future challenges
by: Jing Jin, et al.
Published: (2020-05-01)

Photodynamic immunotherapy of cancers based on nanotechnology: recent advances and future challenges
by: Zhaoyuan Liu, et al.
Published: (2021-05-01)

Pseudoprogression manifesting as recurrent ascites with anti-PD-1 immunotherapy in urothelial bladder cancer
by: Randy F. Sweis, et al.
Published: (2018-04-01)

Development of a Prognostic AI-Monitor for Metastatic Urothelial Cancer Patients Receiving Immunotherapy
by: Stefano Trebeschi, et al.
Published: (2021-04-01)

Is immunotherapy in the future of therapeutic management of sarcomas?
by: Ottavia Clemente, et al.
Published: (2021-04-01)

Incorporating VEGF-targeted therapy in advanced urothelial cancer
by: Sujata Narayanan, et al.
Published: (2017-01-01)

The continuing role of chemotherapy in the management of advanced urothelial cancer
by: Alfonso Gómez De Liaño, et al.
Published: (2018-12-01)

Cannot write session to /tmp/vufind_sessions/sess_08ujdqhtn6cfcihcm4dr7pgt86